HITIQ Limited (HIQ.AX)

0.0540 0.0000 (0.00%) 收市價： 04:10PM AEDT

HITIQ Limited

9-17 Raglan Street
Suite 1 Level 2 South Melbourne
Melbourne, VIC 3205
Australia
61 4 7803 8567
https://hitiq.com

版塊: Healthcare
行業: Health Information Services
全職員工: 25

高階主管

名稱	標題	支付	行使價	出生年份
Mr. Michael Dean Vegar	MD, CEO & Director	231k	無	無
Mr. David Erikson	Chief Technical Officer	220k	無	無
Mr. Thomas Laudenbach	Head of Product & Projects	154k	無	無
Mr. Damien Peter Hawes	Head of Commercial	176k	無	無
Mr. Peter Torre	Company Sec.	無	無	無

截止 2022年12月31日為止計算的金額，現金賠償則計算至上一個財政年度末止。薪資是指薪俸、獎金等。已行使價是指財政年度期間已行使的期權價值。貨幣為 AUD。

描述

HitIQ Limited engages in development and commercialization of concussion management technology in Australia. Its Nexus software provides comprehensive head impact data and analysis to make informed decisions to improve the quality of care for athletes. It also offers CoVR, a virtual reality based cognitive and oculomotor assessment platform, which identifies impairments across domains, such as hand-eye coordination, memory, and decision making; and CSX that provides an easy to use, sideline concussion assessment tool, which produces a digital record that can be shared with medical professionals, family, and organizations to take coordinated athlete care. The company was incorporated in 2015 and is based in Melbourne, Australia.

公司管治

截至 無 止，HITIQ Limited 的 ISS 管治質素評分為 無。 Pillar 分數正在審核中：無；董事會：無；股東權利：無；現金賠償：無。

企業管治評分的資料提供： Institutional Shareholder Services (ISS). 評分將以 1 至 10 分顯示 (與指數或地區相關)。1 分表示較低的管治風險，而 10 分表示較高的管治風險。